Importing Pharmaceuticals for Clinical Trials
Often at the centre of a clinical trial, the cross-border movement of investigational medicinal products (IMP) requires supreme precision, proactivity and planning. Whether shipping your IMPs, standard of care (SOC) drugs, co-treatments, comparators or active pharmaceutical ingredients (APIs), TecEx Medical project manages the entire export-import process to ensure your intellectual property and critical drugs reach patients in time, without delay and fully compliant with the regulations of the country.
Why Pharmaceuticals Matter in Clinical Trials
Pharmaceutical products are the backbone of any clinical trial. Very often these commodities are what ultimately determines the success or failure of the research effort. Without them, patient recruitment stalls, treatment schedules cannot begin, patient dosing is dangerously interrupted and valuable data collection is delayed.
Timely and compliant access to these products is critical. A late delivery of an IMP from a preventable customs query or import license delay can mean missed dosing windows, compromised patient safety, and data sets that regulators may reject. This is over and above the sensitive nature of the products, which raises its own set of concerns when facilitating imports into remote regions, directly-to-sites or through complex regulatory and customs systems that have a tendency to extend clearance timelines.
In short, getting pharmaceuticals to trial sites quickly and compliantly isn’t just a logistical concern, it is essential to maintaining trial momentum, protecting patients, and ensuring credible study results.
Challenges of Importing Pharmaceuticals Globally
Moving pharmaceuticals across borders is never straightforward. Often the high-value nature of the products alone is enough to ensure that extra special attention is paid to the shipment by the authorities.Trial sponsors, CDMOs and CROs often face:
Strict regulatory oversight
APIs and IMPs Pharmaceuticals are among the most tightly controlled commodities in the world. With most country customs gloabl authorities focussed on protecting the inhabitants of their country, Iimport permits, local establishment licenses, and adherence to Good Manufacturing Practice (GMP) are non-negotiable, and requirements vary dramatically from country to by country. Even non-active treatments like saline and water (when used in dosing or placebos) are expected to adhere to the import standard and requirements of the highly regulated products.
Cold chain and handling risks
Many pharmaceuticals must be stored and transported within strict temperature ranges. Customs delays, product seizure, poor packaging, or inadequate IOR infrastructure can quickly compromise product integrity, rendering supplies unusable. Ultimately, unnecessary costs need to be absorbed are incurred by the sponsor/CRO increasing spiking the budget usage that would have preferably been directed to sponsor savings or actual patient treatments and care.
Complex documentation, classification and taxation
Certificates of analysis, clinical trial approvals, valuation methodologies, commodity classifications and product registrations must all be accurate and complete. Even a small paperwork error – or misinterpretation of the correct tariff code to be used – can cause customs authorities to reject, detain or penalize or detain a shipment; ensuring that every shipment undertaken for that trial thereafter going forward is scrutinized to the highest degree.
Severe consequences of missteps
Given the harm unregulated pharmaceuticals can cause amongst a population, authorities tend to treat imports of these products with a high degree of skepticism and scrutiny. Failing to comply with local regulations can lead to seized goods, financial penalties, future import limitations and weeks of delay.
For a clinical trial, this can mean missed patient dosing windows, compromised data integrity, and escalating trial costs.
With each country enforcing its own rules, ensuring compliant imports (or exports) of pharmaceuticals APIs and IMPs adhere to all the publicized (and unpublicized) country requirements rules, industry regulations and port-of-entry preferences, and it can feel overwhelming and confusing to manage across multiple countries and contacts within one study or portfolio.
The TecEx Medical Solution for Pharmaceutical Imports
TecEx Medical delivers trusted import solutions for companies navigating the complexities of clinical trial logistics around the world.
Our end-to-end solution ensures your pharmaceuticals arrive exactly where they’re needed safely, legally, and on time.
Our local partners, compliance experts and project management teams have a clear understanding of how regulatory requirements and clinical timelines evolve. We proactively work with your team to map out projected site demand, phase-specific consumption, and likely contingencies to help you build an import plan that’s resilient, compliant, and scalable.
Importer of Record
Avoid the need for local entities and let us manage all your global imports using our deep domain expertise. Outsourcing this function to a specialist unlocks tremendous value and risk mitigation.
Exporter of Record
Get samples and supplies back where they need to go, fast. We handle complex export regulations and controlled substances so that your exports are seamless and headache-free.
Custom Clearance and Brokerage
99.94% first-time clearance rate with 2.56 days average processing time. Our clinical trial expertise means no more classification errors or unexpected delays.
Regulatory Compliance
We navigate the regulatory maze so you don’t have to. End-to-end compliance from a team of experts who have their finger on the pulse around the world.
VAT/GST Savings
Recover up to 50% of import taxes across 33+ countries. We’ve saved millions in VAT/GST that sponsors thought was lost forever. Minimal effort, maximum return.
With active operations in over 90 countries and an extensive knowledge of pharmaceutical regulations, TecEx Medical is the trusted partner for CROs, CDMOs and sponsors worldwide. We are driven by the same incentives you are — reducing time-to-site, eliminating compliance headaches, derisking stakeholders and saving money through world-class import solution structuring.
One of the highly requested services that we offer our clients when importing pharmaceuticals is to ensure that we, as the specialized IOR, are optimizing the import VAT, duties and taxes incurred on a study.
Import taxes, tariffs and duties can make up more than 50% of clinical trial logistics costs and are usually seen as a sunk line item – often not budgeted for (with their true effect only seen retrospectively once the study is already underway). Preemptively accounting for and implementing optimization and savings techniques on this cost component can radically influence your spend calculations and reduction. This is especially applicable with high-value pharmaceuticals (such as oncology, rare disease, GLP1 and cell-and-gene treatments) where these traditionally ‘sunk’ costs can run into the tens to hundreds of thousands.
TecEx’s relationship with parent company VATIT and our own in-house team of tax experts allow for market-leading solutions to reduce or reclaim these costs for sponsors.
How It Works
As per comment in word doc please supply info graphic
All our solutions are bespoke and tailored specifically to your needs. You won’t find better service or more sophisticated logistics anywhere else.
Ready to Optimize Your Pharmaceutical Imports?
When patient timelines are on the line, you need a logistics partner who gets it right the first time. Let’s work together to move your Pharmaceuticals across borders with confidence.